(Corrects to remove extraneous word ‘record’ from headline)
Dec 17 (Reuters) - Immunoprecise Antibodies Ltd:
* IMMUNOPRECISE ANNOUNCES RECORD QUARTERLY REVENUE AND SIGNIFICANTLY EXPANDS GROSS MARGINS
* IMMUNOPRECISE ANTIBODIES LTD - QTRLY REVENUES OF $3.2 MILLION VERSUS $2.7 MILLION
* IMMUNOPRECISE ANTIBODIES LTD - QTRLY NET LOSS OF $1.4 MILLION
* IMMUNOPRECISE ANTIBODIES LTD - REVENUE OUTLOOK IS POSITIVE FOR Q3 Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.